These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26574634)

  • 1. CMTM8 is Frequently Downregulated in Multiple Solid Tumors.
    Zhang W; Qi H; Mo X; Sun Q; Li T; Song Q; Xu K; Hu H; Ma D; Wang Y
    Appl Immunohistochem Mol Morphol; 2017 Feb; 25(2):122-128. PubMed ID: 26574634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of CMTM8 induces epithelial-to-mesenchymal transition-like changes via c-MET/extracellular signal-regulated kinase (ERK) signaling.
    Zhang W; Mendoza MC; Pei X; Ilter D; Mahoney SJ; Zhang Y; Ma D; Blenis J; Wang Y
    J Biol Chem; 2012 Apr; 287(15):11850-8. PubMed ID: 22337876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Advances in Chemokine-like Factor Super Family Member 8.
    Gao DH; Hu H; Fang ZW; Huo F; Wang HR; Xu KX; Wang XF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Dec; 38(6):746-749. PubMed ID: 28065246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expressions of CMTM8 and E-cadherin in primary and metastatic clear cell renal cell carcinoma].
    Hu H; Chen JW; Xu KX; Wang D; Wang Y; Wang GW; Zhang SY; Wang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 45(4):537-41. PubMed ID: 23939157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMTM8 inhibits the carcinogenesis and progression of bladder cancer.
    Gao D; Hu H; Wang Y; Yu W; Zhou J; Wang X; Wang W; Zhou C; Xu K
    Oncol Rep; 2015 Dec; 34(6):2853-63. PubMed ID: 26503336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of the tumor suppressor CMTM8 and its association with prognosis in bladder cancer.
    Zhang S; Pei X; Hu H; Zhang W; Mo X; Song Q; Zhang Y; Xu K; Wang Y; Na Y
    Tumour Biol; 2016 May; 37(5):6217-25. PubMed ID: 26615421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMTM8 Is a Suppressor of Human Mesenchymal Stem Cell Osteogenic Differentiation and Promoter of Proliferation Via EGFR Signaling.
    H'ng CH; Camp E; Anderson PJ; Zannettino ACW; Gronthos S
    Stem Cells Dev; 2020 Jul; 29(13):823-834. PubMed ID: 32268840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth.
    Li H; Li J; Su Y; Fan Y; Guo X; Li L; Su X; Rong R; Ying J; Mo X; Liu K; Zhang Z; Yang F; Jiang G; Wang J; Zhang Y; Ma D; Tao Q; Han W
    Oncogene; 2014 Jun; 33(24):3109-18. PubMed ID: 23893243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulated CMTM8 Correlates with Poor Prognosis in Gastric Cancer Patients.
    Yan M; Zhu X; Qiao H; Zhang H; Xie W; Cai J
    DNA Cell Biol; 2021 Jun; 40(6):791-797. PubMed ID: 33978454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
    Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
    Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Research Advance in CKLF-like MARVEL Transmembrane Domain Containing Member Family (Review).
    Lu J; Wu QQ; Zhou YB; Zhang KH; Pang BX; Li L; Sun N; Wang HS; Zhang S; Li WJ; Zheng W; Liu W
    Asian Pac J Cancer Prev; 2016; 17(6):2741-4. PubMed ID: 27356683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of CMTM8 polymorphisms on lung cancer susceptibility in the Chinese Han population.
    Wu J; Sun Y; Xiong Z; Niu F; Liu Y; Li H; Liu J; Wu J; Liu Q; Jin T
    Pharmacogenet Genomics; 2021 Jun; 31(4):89-95. PubMed ID: 33395025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research Advances in CKLF-like MARVEL Transmembrane Domain-containing Family in Non-small Cell Lung Cancer.
    Wu K; Li X; Gu H; Yang Q; Liu Y; Wang L
    Int J Biol Sci; 2019; 15(12):2576-2583. PubMed ID: 31754330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer.
    Kang N; Xie X; Zhou X; Wang Y; Chen S; Qi R; Liu T; Jiang H
    BMC Gastroenterol; 2022 Apr; 22(1):190. PubMed ID: 35429970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.
    Hu F; Yuan W; Wang X; Sheng Z; Yuan Y; Qin C; He C; Xu T
    Clin Transl Oncol; 2015 Aug; 17(8):632-9. PubMed ID: 25990505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alternative splice form of CMTM8 induces apoptosis.
    Li D; Jin C; Yin C; Zhang Y; Pang B; Tian L; Han W; Ma D; Wang Y
    Int J Biochem Cell Biol; 2007; 39(11):2107-19. PubMed ID: 17681841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research advances in CKLF-like MARVEL transmembrane domain containing member 5].
    Yuan YQ; Xiao YB; Liu ZH; Zhang XW; Xu T; Wang XF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):625-8. PubMed ID: 23286412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
    Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
    J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMTM3 inhibits human testicular cancer cell growth through inducing cell-cycle arrest and apoptosis.
    Li Z; Xie J; Wu J; Li W; Nie L; Sun X; Tang A; Li X; Liu R; Mei H; Wang F; Wang Z; Gui Y; Cai Z
    PLoS One; 2014; 9(2):e88965. PubMed ID: 24586462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMTM1_v17 is a novel potential therapeutic target in breast cancer.
    Wang J; Zhang G; Zhang Y; Luo Y; Song Q; Qiu X; Mo X; Wang L
    Oncol Rep; 2014 Nov; 32(5):1829-36. PubMed ID: 25175386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.